| Dr Andrea Braun, MD | |
|
6720 Bertner Ave, Baylor St. Luke's Medical Center, Houston, TX 77030-2604 | |
| (832) 355-1000 | |
| Not Available |
| Full Name | Dr Andrea Braun |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 6720 Bertner Ave, Houston, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578785721 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Texas Health System | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcallen Hospitalist Group Pllc | 9830113836 | 99 |
News Archive
Congressional Democrats have begun to "prep for a pre-Thanksgiving budget showdown" with President Bush, as lawmakers seek to finalize a more than $700 billion package that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, CongressDaily reports (Cohn, CongressDaily, 10/29).
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
The National Medicines Symposium 2016 has opened in Canberra today with a keynote address from Dr Stefan Hajkowicz, Senior Principal Scientist from the CSIRO on the megatrends reshaping our world over the coming twenty years, with an emphasis on the importance of innovation and using existing resources more efficiently.
In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.
› Verified 7 days ago
| Entity Name | Mcallen Hospitalist Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356361976 PECOS PAC ID: 9830113836 Enrollment ID: O20060117001076 |
News Archive
Congressional Democrats have begun to "prep for a pre-Thanksgiving budget showdown" with President Bush, as lawmakers seek to finalize a more than $700 billion package that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, CongressDaily reports (Cohn, CongressDaily, 10/29).
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
The National Medicines Symposium 2016 has opened in Canberra today with a keynote address from Dr Stefan Hajkowicz, Senior Principal Scientist from the CSIRO on the megatrends reshaping our world over the coming twenty years, with an emphasis on the importance of innovation and using existing resources more efficiently.
In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.
› Verified 7 days ago
| Entity Name | Baylor St Lukes Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740485879 PECOS PAC ID: 9133213192 Enrollment ID: O20070920000863 |
News Archive
Congressional Democrats have begun to "prep for a pre-Thanksgiving budget showdown" with President Bush, as lawmakers seek to finalize a more than $700 billion package that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, CongressDaily reports (Cohn, CongressDaily, 10/29).
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
The National Medicines Symposium 2016 has opened in Canberra today with a keynote address from Dr Stefan Hajkowicz, Senior Principal Scientist from the CSIRO on the megatrends reshaping our world over the coming twenty years, with an emphasis on the importance of innovation and using existing resources more efficiently.
In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.
› Verified 7 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
Congressional Democrats have begun to "prep for a pre-Thanksgiving budget showdown" with President Bush, as lawmakers seek to finalize a more than $700 billion package that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, CongressDaily reports (Cohn, CongressDaily, 10/29).
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
The National Medicines Symposium 2016 has opened in Canberra today with a keynote address from Dr Stefan Hajkowicz, Senior Principal Scientist from the CSIRO on the megatrends reshaping our world over the coming twenty years, with an emphasis on the importance of innovation and using existing resources more efficiently.
In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrea Braun, MD 6720 Bertner Ave, Baylor St. Luke's Medical Center, Houston, TX 77030-2604 Ph: () - | Dr Andrea Braun, MD 6720 Bertner Ave, Baylor St. Luke's Medical Center, Houston, TX 77030-2604 Ph: (832) 355-1000 |
News Archive
Congressional Democrats have begun to "prep for a pre-Thanksgiving budget showdown" with President Bush, as lawmakers seek to finalize a more than $700 billion package that includes the fiscal year 2008 Defense (HR 3222), Labor-HHS-Education (HR 3043) and Military Construction-Veterans Affairs (HR 2642) appropriations bills, CongressDaily reports (Cohn, CongressDaily, 10/29).
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
The National Medicines Symposium 2016 has opened in Canberra today with a keynote address from Dr Stefan Hajkowicz, Senior Principal Scientist from the CSIRO on the megatrends reshaping our world over the coming twenty years, with an emphasis on the importance of innovation and using existing resources more efficiently.
In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.
› Verified 7 days ago
Dr. Michaela Elizabeth Ginn, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 13214 Indian Creek Road, Houston, TX 77079 Phone: 713-591-3555 Fax: 661-321-3286 | |
Ameena Bagree Malhotra, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, 77030-4009, Houston, TX 77030 Phone: 713-792-6161 | |
Svetang Vijay Desai, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 Fm 1959 Rd, Suite A, Houston, TX 77034 Phone: 281-481-9400 | |
Dr. Stalin R Subramanian, M.D Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 7200 Cambridge St Fl 8, Houston, TX 77030 Phone: 713-798-0950 | |
Robin Boliver-campbell, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 7141 Southwest Fwy, Houston, TX 77074 Phone: 713-771-7921 Fax: 713-264-8659 | |
Henna Mukhtar Malik, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 13215 Dotson Rd Ste 300, Houston, TX 77070 Phone: 281-894-8822 | |
Zaven Sargsyan, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2002 Holcombe Blvd, Department Of Medicine, Houston, TX 77030 Phone: 713-791-1414 |